Puma Biotechnology, Inc. (PBYI)

10.29 +0.32 (+3.21%) USD  |  NASDAQ  |  Oct 09, 16:00
10.29 0.00 (0.00%) After-Hours: 16:10
More

Puma Biotechnology Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for PBYI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Current Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
August 06, 2026 --
May 08, 2026 --
March 31, 2026 --
February 27, 2026 --
February 20, 2026 --
December 31, 2025 --
November 07, 2025 --
August 08, 2025 --
Date Value
June 30, 2025 --
May 16, 2025 --
May 09, 2025 --
February 28, 2025 --
February 21, 2025 --
December 31, 2024 --
November 08, 2024 --
August 02, 2024 --

Revenue Estimates for Current Quarter Range, Past 5 Years

View Revenue Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Quarter Benchmarks

View Revenue Estimates for Current Quarter Benchmarks
Start Trial
Arcutis Biotherapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Savara, Inc. Upgrade
Vericel Corp. Upgrade

Revenue Estimates for Current Quarter Related Metrics

Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade